Evaluation of disease activity in rheumatoid arthritis by Routine Assessment of Patient Index Data 3 (RAPID3) and its correlation to Disease Activity Score 28 (DAS28) and Clinical Disease Activity Index (CDAI): An Indian experience

Clinical Rheumatology

Volumn 31, Issue 12, 2012, Pages 1663-1669

  Singh, H ^a   Gupta, V ^a   Ray, S ^a   Kumar, H ^a   Talapatra, P ^a   Kaur, M ^a   Kumar, S ^b   Arya, S ^a   Mathur, R ^a   Ghangas, N ^a  

^a POST GRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b Maharaja Agrasen Medical College   (India)

Author keywords

Clinical Disease Activity Index (CDAI); Disease activity; Disease Activity Score 28 (DAS28); Rhematoid arthritis; Routine Assessment of Patient Index Data 3 (RAPID3)

Indexed keywords

HEMOGLOBIN;

ADULT; ARTICLE; CLINICAL DISEASE ACTIVITY INDEX; CLINICAL EVALUATION; CLINICAL EXAMINATION; CROSS-SECTIONAL STUDY; DAS28; DISEASE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; INDIAN; JOINT EXAMINATION; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; RADIODIAGNOSIS; REMISSION; RHEUMATOID ARTHRITIS; ROUTINE ASSESSMENT OF PATIENT INDEX DATA 3; SELF REPORT; VISUAL ANALOG SCALE;

ADULT; AGED; ARTHRITIS, RHEUMATOID; DISABILITY EVALUATION; FEMALE; HUMANS; INDIA; JOINTS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PHYSICAL EXAMINATION; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 84872109516     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-012-2070-9     Document Type: Article

References (38)

1. Wolfe F, Cush JJ, O'Dell JR, Kavanaugh A, Kremer JM, Lane NE et al (2001) Consensus recommendations for the assessment and treatment of rheumatoid arthritis. J Rheumatol 28:1423-1430 (Pubitemid 32510520)
2. Fransen J, Stucki G, van Riel P (2002) The merits of monitoring: should we follow all our rheumatoid arthritis patients in daily practice? Rheumatology (Oxford) 41:601-604 (Pubitemid 34618877)
3. Kiely PD, Brown AK, Edwards CJ, O'Reilly DT, Ostör AJ, Quinn M et al (2009) Contemporary treatment principles for early rheumatoid arthritis: a consensus statement. Rheumatology (Oxford) 48:765-772
4. van der Heijde DMFM, van't Hof MA, van Riel PLCM et al (1990) Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 49:916-920 (Pubitemid 20360757)
5. Van Der Heijde DM, van't Hof M, Van Riel PL, Van de Putte LB (1993) Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol 20:579-581 (Pubitemid 23102498)
6. Prevoo ML, van't Hof MA, Kuper HH, Van Leeuwen MA, Van de Putte LB, Van Riel PL (1995) Modified disease activity scores that include 28-joint counts. Development and validation in aprospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44-48
7. Mottonen T, Hannonen P, Leirisalo-Repo M et al (1999) Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo Trial Group. Lancet 353:1568-1573 (Pubitemid 29219206)
8. Puolakka K, Kautiainen H, Möttönen T et al (2005) Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial. Arthritis Rheum 52:36-41 (Pubitemid 40129230)
9. Grigor C, Capell H, Stirling A et al (2004) Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 364:263-269 (Pubitemid 38942816)
10. Goekoop-Ruiterman YPM, de Vries-Bouwstra JK, Allaart CF et al (2005) Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 52:3381-3390 (Pubitemid 41612204)
11. Goekoop-Ruiterman YPM, de Vries-Bouwstra JK, Allaart CF et al (2007) Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial. Ann Intern Med 146:406-415 (Pubitemid 351650575)
12. Verstappen SMM, Jacobs JWG, van der Veen MJ et al (2007) Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). Ann Rheum Dis 66:1443-1449 (Pubitemid 350032650)
13. Pincus T, Yazici Y, Sokka T (2007) Quantitative measures of rheumatic diseases for clinical research versus standard clinical care: differences, advantages and limitations. Best Pract Res Clin Rheumatol 21:601-628 (Pubitemid 47189089)
14. Pincus T, Segurado OG (2006) Most visits of most patients with rheumatoid arthritis to most rheumatologists do not include a formal quantitative joint count. Ann Rheum Dis 65: 820-822 (Pubitemid 43799185)
15. Aletaha D, Smolen J (2005) The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 23:S100-S108 (Pubitemid 46657517)
16. Yazici Y, Bergman M, Pincus T (2008) Time to score quantitative rheumatoid arthritis measures: 28-joint count, disease activity score, health assessment questionnaire (HAQ), multidimensional HAQ (MDHAQ), and routine assessment of patient index data (RAPID) scores. J Rheumatol 35:603-609 (Pubitemid 351500054)
17. Pincus T, Swearingen CJ, Bergman MJ, Colglazier CL, Kaell AT, Kunath AM et al (2010) RAPID3 (Routine Assessment of Patient Index Data) on an MDHAQ (Multidimensional Health Assessment Questionnaire): agreement with DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) activity categories, scored in five versus more than ninety seconds. Arthritis Care Res 62:181-189
18. Pincus T, Swearingen CJ, Bergman M, Yazici Y (2008) RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories. J Rheumatol 35:2136-2147
19. Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR et al (2008) American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 59:762-784 (Pubitemid 351847559)
20. Fransen J, van Riel PLCM (2006) DAS remission cut points. Clin Exp Rheumatol 24:S29-S32 (Pubitemid 44710278)
21. Aletaha D (2006) Pooled indices to measure rheumatoid arthritis activity: a good reflection of the physician's mind? Arthritis Res Ther 8:102-104
22. Aletaha D, Smolen JS (2006) Remission of rheumatoid arthritis: should we care about definitions? Clin Exp Rheumatol 24:S45-S51 (Pubitemid 44696868)
23. Pincus T, Swearingen C, Wolfe F (1999) Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthritis Rheum 42:2220-2230 (Pubitemid 30263609)
24. Pincus T, Sokka T, Kautiainen H (2005) Further development of a physical function scale on a multidimensional Health Assessment Questionnaire for standard care of patients with rheumatic diseases. J Rheumatol 32:1432-1439 (Pubitemid 41113961)
25. Pincus T, Bergman M, Sokka T, Roth J, Swearingen C, Yazici Y (2008) Visual analog scales in formats other than a 10 centimeter horizontal line to assess pain and other clinical data. J Rheumatol 35:1550-1558
26. Yelin E, Meenan R, Nevitt M, Epstein W (1980) Work disability in rheumatoid arthritis: effects of disease, social, and work factors. Ann Intern Med 93:551-556 (Pubitemid 10015177)
27. Pincus T, Callahan LF (1993) What is the natural history of rheumatoid arthritis? Rheum Dis Clin North Am 19:123-151 (Pubitemid 23094221)
28. Wolfe F (1996) The natural history of rheumatoid arthritis. J Rheumatol Suppl 44:13-22 (Pubitemid 26094642)
29. Pincus T (2006) The DAS is the most specific measure, but a patient questionnaire is the most informative measure to assess rheumatoid arthritis. J Rheumatol 33:834-837
30. Pincus T, Strand V, Koch G et al (2003) An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial. Arthritis Rheum 48:625-630 (Pubitemid 36301996)
31. Pincus T, Amara I, Koch GG (2005) Continuous indices of Core Data Set measures in rheumatoid arthritis clinical trials: lower responses to placebo than seen with categorical responses with the American College of Rheumatology 20% criteria. Arthritis Rheum 52:1031-1036 (Pubitemid 40530108)
32. Pincus T, Chung C, Segurado OG, Amara I, Koch GG (2006) An index of patient self-reported outcomes (PRO Index) discriminates effectively between active and control treatment in 4 clinical trials of adalimumab in rheumatoid arthritis. J Rheumatol 33:2146-2152 (Pubitemid 44749771)
33. Pincus T, Bergman MJ, Yazici Y, Hines P, Raghupathi K, Maclean R (2008) An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to Disease Activity Score (DAS28) and other RAPID indices that include physician-reported measures. Rheumatology (Oxford) 47:345-349 (Pubitemid 351267204)
34. Wolfe F, Michaud K, Pincus T (2005) A composite disease activity scale for clinical practice, observational studies and clinical trials: the patient activity scale (PAS/PAS-II). J Rheumatol 32:2410-2415 (Pubitemid 41780656)
35. Pincus T (2008) Limitations of a quantitative swollen and tender joint count to assess and monitor patients with rheumatoid arthritis. Bull NYU Hosp Jt Dis 66:216-223
36. Coury F, Rossat A, Tebib A, Letroublon MC, Gagnard A, Fantino B et al (2009) Rheumatoid arthritis and fibromyalgia: a frequent unrelated association complicating disease management. J Rheumatol 36:58-62
37. Makinen H, Hannonen P (2009) How to assess patients with rheumatoid arthritis and concomitant fibromyalgia? J Rheumatol 36:9-11
38. Pincus T, Wolfe F (2005) Patient questionnaires for clinical research and improved standard patient care: is it better to have 80% of the information in 100% of patients or 100% of the information in 5% of patients? J Rheumatol 32:575-577 (Pubitemid 40524685)